APPLICATIONS PUBLISHED 11 SEPTEMBER 2002
Published: 1-Mar-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Stable, high glycerol liquids comprising sulphosuccinic acid monoesters
Unilever 1237534*
Compsns for effective release of active ingredients
Procter & Gamble 1237535*
The use of fluorescent whitening agents
Ciba Specialty Chemicals Holding 1237536*
Compsn in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production
Investigations Therapeutiques Essais Cliniques Services 1237537*
An improved pharmaceutical compsn for treating male erectile dysfunction
Natco Pharma 1237538*
Oral solution containing galanthamine and a sweetening agent
Janssen Pharmaceutica 1237539*
Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal services
Atrix Laboratories 1237540*
Liposomes
Lipoixen Technologies 1237541*
Effervescent histamine H2 antagonist compsn
Bristol-Myers Squibb 1237543*
System and method for extended delivery of a therapeutic agent with its receptor loading dose
Trident Technologies 1237544*
Use of G(A)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer
Monsanto Technology 1237545*
Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases
Institute of Molecular and Cell Biology 1237546*
Compounds for inhibiting diseases and preparing cells for transplantation
Isis Innovation; Queen's University at Kingston 1237547*
IL-8 receptor antagonists
SmithKline Beecham 1237548*
Lipoxin A4 and its analogues for the treatment of dry eye
Alcon 1237549*
Methods for treating cell death diseases and inflammation
President and Fellows of Harvard College 1237550*
Pharmaceutical formulations comprising zolmitriptan
AstraZeneca 1237552*
Combination of an ergoline and riluzone for preventing and treating motor neurone diseases
Aventis Pharma 1237552*
The combination of a serotonin reuptake-uptake inhibitor and a 5-HT 2C antagonist, inverse agonist or partial agonist
H Lundbeck 1237553*
Use of sodium channel antagonists for the treatment of diseases related to apoptosis
Glaxo Group 1237554*
Implant compsn containing mellengestrol acetate and trenbolone acetate
Pharmacia & Upjohn 1237555*
Pharmaceutical implant containing immediate release and sustained release components and method of administration
Pharmacia & Upjohn 1237556*
Galenical preparations of sapsone and related sulphones, and method for therapeutic and preventative treatment of disease
Immune Network Research 1237557*
Novel Helicobacter pylori-binding substances and use thereof
A+ Science Invest 1237558*
Pharmaceutical combinations
AstraZeneca 1237559*
Regenerative adjuvant (3-way tap)
Curasan 1237560*
Use of honey in medical dressings
Waikatolink 1237561*
DNA polymerase inhibitors, mikanolide and dihyromikanolide
Societe de Conseils de Recherches et d'Applications Scientifiques 1237562*
Nutritional compsn, methods of producing said compsn and methods of using said compsn
Siskind, Harry 1237563*
Inducing cellular immune responses to P53 using peptide and nucleic acid compsns
Epimmune 1237564*
Betaglycan as an inhibin receptor and uses thereof
Research Development Foundation 1237565*
Intraspinal compsns containing botulinum toxin for treating pain
Allergan Sales 1237566*
Method for administering a cytokine to the central nervous system and the lymphatic system
Chiron Corp 1237567*
A conjugate of a collagen II-binding fragment and an arthritis-affecting pharmaceutical substance
Anamar Medical 1237568*
Fragments and antagonists of heat shock protein 60
Peptor 1237570*
Toscana virus nucleoprotein
Universitat Degli Studi di Siena 1237571*
Use of inactivated immunosuppresive or angiogenic immunogenic proteins for producing secretory IGAs
Neovacs 1237573*
Antigen delivery
Actinova 1237574*
TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorders
Genentech 1237575*
Antiviral agent for use in treatment of cancer
Institut Gustave Roussy 1237576*
Transmucosal compsn containing a phosphodiesterase inhibitor for the treatment of erectile dysfunction
Vivus 1237577*
Micro-cluster liquids and methods of making and using them
Bio-hydration Research Lab 1237578*
Surfactants as malarial chloroquine resistance reversal agents
Kain, Kevin; Crandall, Ian; Charuk, Jeffrey; Reithmeier, Reinhart 1237579*
Amphiphilic polymers and polypeptide conjugates comprising same
Nobex 1237580*
Use of cationic lipids for intracellular protein delivery
Gene Therapy Systems 1237581*
Methods for introducing genes into mammalian subjects
Anticancer 1237582*
Near infrared fluorescent contrast agent and fluorescence imaging
Schering; Fuji Photo Film 1237583*
Receptor binding conjugates
Anticancer Therapeutic Inventions 1237584*
